Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for IRWD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 -0.303M
March 31, 2026 0.00
December 31, 2025 -0.122M
September 30, 2025 0.00
June 30, 2025 -0.088M
March 31, 2025 -0.006M
December 31, 2024 -0.203M
September 30, 2024 0.00
June 30, 2024 -0.749M
March 31, 2024 -10.06M
December 31, 2023 -0.998M
September 30, 2023 -0.012M
June 30, 2023 -1.366M
March 31, 2023 -3.981M
December 31, 2022 -2.806M
September 30, 2022 -0.797M
June 30, 2022 29.58M
March 31, 2022 90.87M
December 31, 2021 18.59M
September 30, 2021 -6.164M
June 30, 2021 -5.662M
March 31, 2021 -2.211M
December 31, 2020 -3.524M
September 30, 2020 -0.67M
June 30, 2020 -2.397M
Date Value
March 31, 2020 -11.96M
December 31, 2019 -6.447M
September 30, 2019 -1.944M
June 30, 2019 -1.717M
March 31, 2019 -3.487M
December 31, 2018 -4.909M
September 30, 2018 -8.108M
June 30, 2018 -12.84M
March 31, 2018 -6.203M
December 31, 2017 -6.991M
September 30, 2017 -0.906M
June 30, 2017 -10.30M
March 31, 2017 -8.171M
December 31, 2016 -14.29M
September 30, 2016 -4.39M
June 30, 2016 -4.322M
March 31, 2016 -1.841M
December 31, 2015 -2.322M
September 30, 2015 -0.933M
June 30, 2015 -2.995M
March 31, 2015 -7.946M
December 31, 2014 -8.936M
September 30, 2014 -2.741M
June 30, 2014 -7.212M
March 31, 2014 -194.28M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Rigel Pharmaceuticals, Inc. -1.353M
AbbVie, Inc. 9.00M
Marker Therapeutics, Inc. 0.00
Theriva Biologics, Inc. 0.00
Fortress Biotech, Inc. -0.091M